Changes in specific domains of sexual function and sexual bother after radical prostatectomy

BJU International

Volumn 106, Issue 7, 2010, Pages 1022-1029

  Le, Jesse D ^a   Cooperberg, Matthew R ^a   Sadetsky, Natalia ^a   Hittelman, Adam B ^b   Meng, Maxwell V ^a   Cowan, Janet E ^a   Latini, David M ^c   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

prostate cancer; quality of life; radical prostatectomy; sexual bother; sexual function

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SURGERY; COMORBIDITY; CONVALESCENCE; ERECTILE DYSFUNCTION; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; CLINICAL TRIAL; EPIDEMIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL BEHAVIOR; TIME;

AGED; EPIDEMIOLOGIC METHODS; HUMANS; LIBIDO; MALE; MIDDLE AGED; PENILE ERECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RECOVERY OF FUNCTION; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 77956622408     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09231.x     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009 59 : 225 249
2. Noldus J, Graefen M, Haese A, Henke RP, Hammerer P, Huland H. Stage migration in clinically localized prostate cancer. Eur Urol 2000 38 : 74 8
3. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005 23 : 8146 8151
4. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 293 : 2095 2101 (Pubitemid 40617061)
5. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 2001 166 : 947 952
6. Hu JC, Elkin EP, Pasta DJ et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004 171 : 703 707
7. Litwin MS, Gore JL, Kwan L et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007 109 : 2239 2247
8. White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database. J Urol 2008 180 : 2409 2413
9. Albertsen PC, Nease RF, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol 1998 159 : 158 163
10. Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003 169 : 1653 1661
11. Penson DF, McLerran D, Feng Z et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol 2008 179 : S40 4
12. Schover LR, Fouladi RT, Warneke CL et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002 95 : 1773 1785
13. Dahn Jr. Penedo FJ, Gonzalez JS et al. Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology 2004 63 : 273 277
14. Koeman M, van Driel MF, Schultz WC, Mensink HJ. Orgasm after radical prostatectomy. Br J Urol 1996 77 : 861 864
15. Barnas JL, Pierpaoli S, Ladd P et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 2004 94 : 603 605
16. Cooperberg MR, Koppie TM, Lubeck DP et al. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from. Capsure Urol 2003 61 : 190 196
17. Litwin MS, Hays RD, Fink A et al. Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998 36 : 1002 1012
18. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280 : 969 974 (Pubitemid 28445094)
19. Cooperberg MR, Broering JM, Litwin MS et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004 171 : 1393 1401
20. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. J Urol 2003 170 : 1291 1294
21. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol 2009 181 : 462 471
22. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000 56 : 899 905
23. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 : 822 830
24. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005 17 : 307 319
25. Jeffery DD, Tzeng JP, Keefe FJ et al. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer 2009 115 : 1142 1153
26. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999 54 : 346 351
27. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, PeÒa BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11 : 319 326
28. Schroeck FR, Donatucci CF, Smathers EC et al. Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer 2008 113 : 2687 2694
29. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor). Urology 1999 54 : 503 508
30. Michl UH, Friedrich MG, Graefen M, Haese A, Heinzer H, Huland H. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. J Urol 2006 176 : 227 231
31. Knight SJ, Latini DM, Hart SL et al. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer 2007 109 : 1769 1776
32. Stanford JL, Feng Z, Hamilton AS et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000 283 : 354 360
33. Matthew AG, Goldman A, Trachtenberg J et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol 2005 174 : 2105 2110